Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
ANI Pharmaceuticals has agreed to acquire the New Drug Applications for purified corticotropin gel and corticotropin-zinc hydroxide from pharma giant Merck & Co. 21 September 2015
Generics
Albany Molecular Research on Tuesday said it expects the acquisition of Gadea Pharmaceutical to add over 50% to its full year contract revenue and over 40% for adjusted per share earnings. 15 September 2015
Generics
Netherlands-incorporated generic drugmaker Mylan has officially initiated its hostile takeover bid for Ireland-based Perrigo, following public rejections from the management. 15 September 2015
Generics
Netherlands-incorporated generic drugmaker Mylan said it will launch a $27.1 billion hostile takeover bid for the Ireland-based company Perrigo. 9 September 2015
Generics
Indian drugmaker Cipla has entered into definitive agreements to acquire two USA-based companies, InvaGen Pharmaceuticals and Exelan Pharmaceutics. 4 September 2015
Generics
Netherlands-incorporated Mylan that its shareholders have approved its proposed $33 billion hostile acquisition of Ireland-based Perrigo at an extraordinary general meeting of shareholders held today. 28 August 2015
Generics
Generic drug company Alvogen said it has agreed to buy a portfolio of four pharmaceutical products, in the USA, from pharma giant Pfizer in a bid to further diversify and strengthen its commercial platform in the US market. 27 August 2015
Generics
The US Federal Trade Commission has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to US pharma giant Pfizer’s pending acquisition of Hospira 24 August 2015
Generics
Netherlands-incorporated Mylan said it now needs just over 50% shares in hostile takeover target Perrigo to control the company. 14 August 2015
Generics
Moody's Investors Service has affirmed the Baa3 senior unsecured rating of Netherlands-incorporated Mylan and changed the outlook to negative from developing. 1 August 2015
Generics
Israel-based Teva Pharmaceutical Industries is well positioned to make a substantial return on investment from the acquisition of Allergan’s generics business, GlobalData has said. Teva has indicated the deal will lead to annual cost synergies and tax savings of about $1.4 billion. 30 July 2015
Generics
Jordon-based drugmaker Hikma Pharmaceuticals says it has agreed to acquire Roxane Laboratories Inc and Roxane Inc from German family-owned pharma major Boehringer Ingelheim. 28 July 2015
Generics
Generics specialist Mylan has moved to block a hostile takeover bid by Israeli company Teva by setting up an independent Dutch foundation which has exercised its call option to acquire preferred shares in Mylan. 24 July 2015
Generics
Albany Molecular Research says it has acquired all the outstanding shares of Gadea Pharmaceutical, a privately-held company located in Valladolid, Spain. 16 July 2015
Generics
According to sources close to the matter, Israel-based Teva Pharmaceutical Industries is considering upping its offer to buy US generic drugmaker Mylan by as much as $2 billion. 7 July 2015
Generics
Indian drugmaker Lupin (BSE: 500257) has announced a second acquisition in the last couple months, this time taking a 100% equity stake in ZAO Biocom in Russia subject to certain closing conditions. 3 July 2015
Generics
A consortium of investors led by CVC Capital Partners and including Singapore-based investment company Temasek and Vatera Healthcare Partners have acquired a controlling stake in USA-based generic drugmaker Alvogen. 22 June 2015
Generics
Privately-held Irish drugmaker Altan Pharma says it has acquired a privately held group of Spanish companies, the GES Group. 11 June 2015
Generics
Indian drugmaker Cadila Healthcare is nearing a deal to buy the generic sterile injectables business of rival Claris Lifesciences, according to sources close to the matter. 22 May 2015
Generics
Strides Arcolab has signed definitive agreements with certain wholly-owned subsidiaries of South Africa’s Aspen Pharmacare to acquire a generic pharmaceutical business in Australia together with certain branded pharma assets. 21 May 2015
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze